Atlas Trials

Statin TReatment for COVID-19 to Optimise NeuroloGical recovERy

Clinical trial NCT04904536 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT04904536
Sponsor
The George Institute
Status
ACTIVE_NOT_RECRUITING
Phase
Phase 3
Study type
INTERVENTIONAL
Neurocognitive Impairment, Mild
Start date
2022-03-10
Primary completion
2025-06-30
Enrollment
190

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.